BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hausdorff WP, Scheele S, Giersing BK. What Drives the Value of a Shigella Vaccine? Vaccines 2022;10:282. [DOI: 10.3390/vaccines10020282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Maclennan CA, Steele AD. Frontiers in Shigella Vaccine Development. Vaccines 2022;10:1536. [DOI: 10.3390/vaccines10091536] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Maclennan CA, Grow S, Ma L, Steele AD. The Shigella Vaccines Pipeline. Vaccines 2022;10:1376. [DOI: 10.3390/vaccines10091376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mooney J, Price J, Bain C, Bawa JT, Gurley N, Kumar A, Liyanage G, Mkisi RE, Odero C, Seck K, Simpson E, Hausdorff WP. Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries. PLoS ONE 2022;17:e0270369. [DOI: 10.1371/journal.pone.0270369] [Reference Citation Analysis]
4 Nasrin S, Haque MA, Palit P, Das R, Mahfuz M, Faruque ASG, Ahmed T. Incidence of Asymptomatic Shigella Infection and Association with the Composite Index of Anthropometric Failure among Children Aged 1–24 Months in Low-Resource Settings. Life 2022;12:607. [DOI: 10.3390/life12050607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]